The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Anti-cancer potential of flavonoids: recent trends and future perspectives
Open accessAbstract
Cancer is a major public health concern in both developed and developing countries. Several plant-derived anti-cancer agents including taxol, vinblastine, vincristine, the campothecin derivatives, topotecan, irinotecan and etoposide are in clinical use all over the world. Other promising anti-cancer agents include flavopiridol, roscovitine, combretastatin A-4, betulinic acid and silvestrol. From this list one can well imagine the predominance of polyphenols, flavonoids and their synthetic analogs in the treatment of ovarian, breast, cervical, pancreatic and prostate cancer. Flavonoids present in human diet comprise many polyphenolic secondary metabolites with broad-spectrum pharmacological activities including their potential role as anti-cancer agents. A positive correlation between flavonoids-rich diet (from vegetables and fruits) and lower risk of colon, prostate and breast cancers lead to a question that whether flavonoids mediate the protective effects as chemopreventive agents or can interact with different genes and proteins to play role in chemotherapy. The current review emphasizes onto the therapeutic potential of flavonoids and their synthetic analogs as anti-cancer agents by providing new insights into the factors, regulation and molecular mechanisms along with their significant protein interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–232 of 232
Flavonoid Intake and Risk of Pancreatic Cancer in Male Smokers (Finland)
Bobe, G., Weinstein, S. J., Albanes, D., Hirvonen, T., Ashby, J., Taylor, P. R., Virtamo, J. R. K., & Stolzenberg‐Solomon, R. Z. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2523 · Cited by 76
Pérez-Victoria, J. M., Chiquero, M. J., Conseil, G., Dayan, G., Pietro, A. D., Barron, D., Castanys, S., & Gamarro, F. (1999) · Biochemistry · doi:10.1021/bi982455v · Cited by 75
Circulating enterolactone and risk of breast cancer: a prospective study in New York
Zeleniuch‐Jacquotte, A., Adlercreutz, H., Shore, R. E., Koenig, K. L., Kato, I., Arslan, A. A., & Toniolo, P. G. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601893 · Cited by 74
Absorption, metabolism and bioavailability of flavonoids.
Hollman, P. C. H., & Katan, M. (1997) · Socio-Environmental Systems Modeling · Cited by 74
Serum enterolactone levels and the risk of breast cancer in women with palpable cysts
Boccardo, F., Lunardi, G. L., Guglielmini, P., Parodi, M. A., Murialdo, R., Schettini, G., & RUBAGOTTI, A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00576-8 · Cited by 73
D'Alessandro, T. L., PRASAIN, J. K., Benton, M. R., Botting, N. P., Moore, R., Darley-Usmar, V. M., Patel, R. P., & Barnes, S. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3773s · Cited by 71
Arnold, R. S., He, J., Remo, A., Ritsick, D. R., Yin-Goen, Q., Lambeth, J. D., Datta, M. W., Young, A. N., & Petros, J. A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061144 · Cited by 66
Wallström, P., Wirfält, E., Janzon, L., Mattisson, I., Elmståhl, S., Johansson, U., & Berglund, G. L. (2000) · Public Health Nutrition · doi:10.1017/s1368980000000306 · Cited by 61
Oršolić, N., Benković, V., Lisičić, D., Đikić, D., Erhardt, J., & Knežević, A. H. (2009) · Medical Oncology · doi:10.1007/s12032-009-9387-5 · Cited by 60
A food pattern that is predictive of flavonol intake and risk of pancreatic cancer
Nöthlings, U., Murphy, S. P., Wilkens, L. R., Boeing, H., Schulze, M. B., Bueno-de-Mesquita, H. B., Michaud, D. S., Roddam, A., Rohrmann, S., Tjønneland, A. M., et al. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26398 · Cited by 58
The Flavonoid Quercetin Regulates Growth and Gene Expression in Rat FRTL-5 Thyroid Cells
Giuliani, C., Noguchi, Y., Harii, N., Napolitano, G., Tatone, D., Bucci, I., Piantelli, M., Monaco, F., & Kohn, L. D. (2007) · Endocrinology · doi:10.1210/en.2007-0618 · Cited by 58
Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.
Oikawa, T., Shimamura, M., ASHING, H., Nakamura, O., Kanayasu, T., Morita, I., & Murota, S. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1155 · Cited by 56
Wiegand, H., Boesch, C., Regos, I., Treutter, D., Wolffram, S., & Rimbach, G. H. (2009) · Nutrition and Cancer · doi:10.1080/01635580902825621 · Cited by 55
Treatment of Corneal Neovascularization with Dietary Isoflavonoids and Flavonoids
Joussen, A. M., Rohrschneider, K., Reichling, J., Kirchhof, B., & Kruse, F. E. (2000) · Experimental Eye Research · doi:10.1006/exer.2000.0900 · Cited by 55
Amin, A. R. M. R., Thakur, V. S., Paul, R. K., Feng, G. S., Qu, C., Mukhtar, H., & Agarwal, M. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700642104 · Cited by 52
Marchetti, F., Santi, C. D., Vietri, M., Pietrabissa, A., Spisni, R., Mosca, F., & Pacifici, G. M. (2001) · Xenobiotica · doi:10.1080/00498250110069159 · Cited by 51
Antiproliferative Effect of Chrysin on Anaplastic Thyroid Cancer
Phan, T., Yu, X.-M., Kunnimalaiyaan, M., & Chen, H. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.03.064 · Cited by 51
Handbook of Mammalian Metabolism of Plant Compounds (1991)
Scheline, R. R. (2017) · CRC Press eBooks · doi:10.1201/9780203712504 · Cited by 51
CH 6 Dietary Flavonoids and Health — Broadening the Perspective
Andersen, O. M., & Markham, K. R. (2005) · CRC Press eBooks · doi:10.1201/9781420039443-10 · Cited by 43
Fish, Vitamin D, and Flavonoids in Relation to Renal Cell Cancer Among Smokers
Wilson, R. T., Wang, J., Chinchilli, V. M., Richie, J. P., Virtamo, J. R. K., Moore, L. E., & Albanes, D. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp178 · Cited by 41
Wagner, H., & Farkas, L. (1975) · Springer eBooks · doi:10.1007/978-1-4899-2909-9_4 · Cited by 39
Brueggemeier, R. W., GU, X., Mobley, J. A., Joomprabutra, S., Bhat, A., & Whetstone, J. L. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03986.x · Cited by 35
Flavonoid— Protein Interactions
Dangles, O., & Dufour, C. (2005) · CRC Press eBooks · doi:10.1201/9781420039443.ch9 · Cited by 31
Inhibitory effects of Broccolini leaf flavonoids on human cancer cells
Wang, B., & Zhang, X. (2011) · Scanning · doi:10.1002/sca.20278 · Cited by 28
Rodriguez‐Proteau, R., Mata, J. E., Miranda, C. L., et al. (2006) · Xenobiotica · doi:10.1080/00498250500433545 · Cited by 27
Yang, Z. F., Poon, R. T. P., Liu, Y., Lau, C. K., Ho, D. W., Tam, K. H., Lam, C. T., & Fan, S. T. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0149 · Cited by 24
Sivoňová, M. K., Žitňanová, I., Horáková, Ľ., Štrosová, M., Muchová, J., Balgavý, P., Dobrota, D., & Ďuračková, Z. (2006) · PubMed · Cited by 19
Overview of the chemistry of soy isoflavones, potential threats and potential therapeutic benefits.
Ogbuewu, I. P., Uchegbu, M. C., Emenalom, O. O., Okoli, I. C., & Iloeje, M. U. (2010) · Electronic journal of environmental, agricultural and food chemistry · Cited by 17
The Fate of Orally and Parenterally Administered Flavonoids in the Mammal
Griffiths, L. A., & Barrow, A. (2008) · Angiologica · doi:10.1159/000157929 · Cited by 17
Anticancer activity of total flavonoids isolated from Xianhe Yanling Recipe (仙鹤延龄方)
Liu, P., Gao, J. Q., Chen, Y., Long, W., Shen, X., & Wei-sheng, T. (2011) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-011-0644-z · Cited by 11
The Cellular and Molecular Properties of Flavinoids in Prostate Cancer Chemoprevention
Haddad, A. (2008) · TSpace (University of Toronto) · Cited by 4
Molepo, R. S. (2011) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
Cited by
Flavonoids in Cancer and Apoptosis
Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers11010028 · Cited by 751
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
Mutha, R. E., Tatiya, A. U., & Surana, S. J. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00161-8 · Cited by 626
Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
Hashemzaei, M., Far, A. D., Yari, A., Heravi, R. E., Tabrizian, K., Taghdisi, S. M., Sadegh, S. E., Tsarouhas, K., Kouretas, D., Tzanakakis, G., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5766 · Cited by 520
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
Kawser Hossain, M., Abdal Dayem, A., Han, J., Yin, Y., Kim, K., Kumar Saha, S., Yang, G.-M., Choi, H., & Cho, S.-G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040569 · Cited by 495
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Self-citation
Metadata
- Authors
- Batra, P., & Sharma, A. K.
- Venue
- 3 Biotech
- Published
- 2013-02-12
- Volume
- 3
- Issue
- 6
- Pages
- 439-459
- ISSN
- 2190-572X (ISSN-L)
- 2190-5738
- OpenAlex
- W2143626453
- Cited by
- 550
- References
- 232
- FWCI
- 11.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.